Navigation Links
TorkLaw Accepting DePuy Hip Implant Cases
Date:1/25/2013

LOS ANGELES, Jan. 25, 2013 /PRNewswire/ -- The Torkzadeh Law Firm (TorkLaw) is currently pursuing cases against Johnson & Johnson in regards to the defective DePuy ASR hip implants which were recalled in 2010.

As the first trial against Johnson & Johnson gets set to begin in California, newly unsealed court documents of pretrial testimony shows that the company had internal data and analysis that estimated failure in nearly 40 percent of all DePuy ASR Hip Implants.

The DePuy Hip Implants were released to the public in 2008 by Johnson & Johnson, and nearly 100,000 were implanted in patients around the world.  The Food and Drug Administration issued a recall in August 2010 citing the defective manufacturing procedures and unacceptably high failure rates.  There are currently over 10,000 lawsuits filed on behalf of individuals against J&J over its defective DePuy hip implants across the country.

"Since the litigation began against Johnson & Johnson, we are now seeing for the first time what data they had regarding the safety and integrity of their DePuy hip implants.  It is rather alarming what they decided to do with that information," said Reza Torkzadeh , lead product liability lawyer at TorkLaw.

Internal documents and pretrial testimony by J&J representatives show data and analysis of a failure rate of nearly 40% in about four and a half years.  Representatives for J&J previously disputed such failure rates.

"Thousands of individuals have been severely impacted by these defective hip implants.  Most will be living with pain forever, have gone through a serious revision surgery and others won't ever be the same again.  It's time that the truth came out, and that companies like Johnson & Johnson are held accountable for the products they intend to sell to the public.  We must send a message that their profits cannot come at the expense of consumers lives and wellbeing" said Torkzadeh, who's law firm is actively pursuing DePuy Hip Implant cases.

TorkLaw is an award winning nationally recognized personal injury law firm focused on representing victims of defective products and medical devices, dangerous pharmaceuticals, catastrophic injury and wrongful death claims.  For more information on the DePuy hip implant recall and lawsuits call now for a free consultation 888.222.8286 or www.torklaw.com


'/>"/>
SOURCE The Torkzadeh Law Firm
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. TorkLaw Accepting St. Jude Medical Device Cases
2. Attention Veterans: New Medtech Job Training Program Accepting Applications through Friday, August 31
3. Fogarty Institute for Innovation Accepting Applications for Advanced Endovascular Training Fellowship
4. DePuy & Transvaginal Mesh Lawsuit Settlement Funding Leads Legal-Bay to Banner 2nd Quarter
5. DePuy Settlement News In Bellwether Case Concerns Plaintiffs Of The Hip Recall
6. DePuy Mitek Expands Commitment To Youth Sports Safety Through New Sports Injury Prevention Program
7. Sports Injury Prevention Program, Sponsored By DePuy Mitek, Comes To Tampa With Soccer Star Heather Mitts
8. DePuy Settlement Funding And Transvaginal Mesh Capital Increased At Legal-Bay
9. STAAR Surgical Celebrates Over 300,000 Successful Visian® ICL Implants at ASCRS Congress
10. ulrich medical USA™ Releases New Expandable Spinal Implant for US Market
11. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal their media ... Pro X," said Christina Austin - CEO of Pixel Film Studios. , ProSlice ... X users can now reveal the media of their split screens with growing ...
(Date:6/26/2016)... (PRWEB) , ... June 27, 2016 , ... Quality metrics ... yet in many ways they remain in the eye of the beholder, according to ... a publication of The American Journal of Managed Care. For the full issue, ...
(Date:6/26/2016)... , ... June 26, 2016 , ... ... once they have been diagnosed with endometriosis. These women need a treatment plan ... require a comprehensive approach that can help for preservation of fertility and ultimately ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... First ... United States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell ... facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published ... unfamiliar with. The article goes on to state that individuals are now more comfortable ... less common operations such as calf and cheek reduction. The Los Angeles area medical ...
Breaking Medicine News(10 mins):